Literature DB >> 29059286

Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension.

Gema Ruiz-Hurtado1, Luis M Ruilope1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29059286     DOI： 10.1093/eurheartj/ehx560

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

Review 1.  Novel antihypertensive agents for resistant hypertension: what does the future hold?

Authors:  Vincent D Salvador; George L Bakris
Journal:  Hypertens Res       Date:  2022-09-27       Impact factor: 5.528

2.  Anti-Hypertensive Effect of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Renato De Vecchis; Silvia Soreca; Carmelina Ariano
Journal:  Cardiol Res       Date:  2019-02-24

Review 3.  A Meta-Analysis on the Effect and Safety of LCZ696 in the Treatment of Hypertension.

Authors:  Li Zheng; Binbin Xia; Xuqian Zhang; Yan Zhao
Journal:  Cardiol Res Pract       Date:  2021-03-20       Impact factor: 1.866

4.  The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure.

Authors:  Haiping Du; Xiao Li; Weifang Zhao; Ning Jiang
Journal:  J Healthc Eng       Date:  2022-02-18       Impact factor: 2.682

5.  A New Approach for Hypertension: the Case of Sacubitril/Valsartan Experienced in Randomized Controlled Trials That Selectively Restrict Its Use to the Hypertension of the Elderly.

Authors:  Renato De Vecchis; Carmelina Ariano; Silvia Soreca
Journal:  J Clin Med Res       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.